Jianying Zhou Selected Research

Jianying Zhou Research Topics

Disease

54	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 04/2002
41	Neoplasms (Cancer) 04/2022 - 03/2009
19	Lung Neoplasms (Lung Cancer) 01/2022 - 03/2009
13	Disease Progression 10/2022 - 08/2011
13	Adenocarcinoma of Lung 01/2022 - 06/2009
11	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2015
8	Diarrhea 01/2022 - 07/2014
8	Exanthema (Rash) 01/2022 - 09/2013
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2016
6	Asthma (Bronchial Asthma) 01/2021 - 07/2010
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2015
5	Infections 10/2020 - 05/2016
4	COVID-19 01/2021 - 01/2020
3	Adenocarcinoma 01/2022 - 01/2021
3	Carcinoma (Carcinomatosis) 10/2021 - 09/2015
3	Pulmonary Aspergillosis 01/2021 - 04/2018
3	Brain Neoplasms (Brain Tumor) 12/2020 - 06/2015
3	Pleural Effusion (Pleural Effusions) 01/2017 - 01/2015
2	Breast Neoplasms (Breast Cancer) 03/2022 - 01/2017
2	Atrophy 01/2022 - 06/2020
2	Muscular Atrophy (Muscle Atrophy) 01/2022 - 06/2020
2	Lymphatic Metastasis 01/2022 - 09/2016
2	Dyspnea (Shortness of Breath) 10/2021 - 01/2018
2	Thalassemia 10/2021 - 01/2020
2	Sepsis (Septicemia) 02/2021 - 02/2016
2	Bacteremia 02/2021 - 03/2019
2	Neutropenia 01/2021 - 10/2018
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 01/2019
2	Nausea 01/2021 - 12/2020
2	Vision Disorders (Hemeralopia) 01/2021 - 10/2018
2	Leukopenia 01/2021 - 10/2018
2	Vomiting 01/2021 - 12/2020
2	Critical Illness (Critically Ill) 05/2020 - 01/2020
2	Hypertension (High Blood Pressure) 01/2020 - 01/2018
2	Fever (Fevers) 01/2020 - 01/2015
2	Chronic Obstructive Pulmonary Disease (COPD) 12/2019 - 01/2019
2	Lung Diseases (Lung Disease) 01/2019 - 01/2014
2	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 02/2012
2	Malignant Pleural Effusion 01/2017 - 06/2015
2	Inflammation (Inflammations) 01/2017 - 11/2012
2	Respiratory Hypersensitivity 01/2017 - 11/2012

Drug/Important Bio-Agent (IBA)

20	ErbB Receptors (EGF Receptor)IBA 01/2022 - 07/2010
11	CrizotinibIBA 11/2021 - 01/2015
10	Proteins (Proteins, Gene)FDA Link 04/2021 - 04/2002
10	Anaplastic Lymphoma KinaseIBA 12/2020 - 01/2014
9	Tyrosine Kinase InhibitorsIBA 01/2022 - 08/2011
8	CytokinesIBA 01/2022 - 03/2009
8	Gefitinib (Iressa)FDA Link 01/2022 - 09/2013
7	Biomarkers (Surrogate Marker)IBA 12/2021 - 09/2017
7	icotinibIBA 01/2021 - 08/2011
6	Pemetrexed (MTA)FDA Link 01/2021 - 10/2012
5	Interleukin-17 (Interleukin 17)IBA 01/2022 - 07/2010
5	LigandsIBA 04/2021 - 03/2009
5	PlatinumIBA 01/2021 - 08/2011
4	Pharmaceutical PreparationsIBA 01/2022 - 05/2020
4	Immune Checkpoint InhibitorsIBA 12/2021 - 01/2019
4	B7-H1 AntigenIBA 05/2021 - 09/2017
4	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021 - 01/2020
4	Alanine Transaminase (SGPT)IBA 01/2021 - 01/2020
4	Messenger RNA (mRNA)IBA 01/2020 - 01/2015
3	deguelinIBA 01/2022 - 01/2016
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2014
3	p38 Mitogen-Activated Protein KinasesIBA 11/2021 - 03/2016
3	Bevacizumab (Avastin)FDA Link 02/2021 - 12/2019
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 06/2011
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 06/2011
3	NivolumabIBA 01/2021 - 01/2019
3	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 06/2011
3	Transaminases (Aminotransferases)IBA 10/2018 - 07/2014
2	Docetaxel (Taxotere)FDA Link 03/2022 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 03/2022 - 03/2009
2	aumolertinibIBA 01/2022 - 01/2022
2	Immunoglobulin E (IgE)IBA 01/2022 - 01/2021
2	Monoclonal AntibodiesIBA 01/2022 - 12/2019
2	Biological ProductsIBA 01/2022 - 01/2020
2	Heparin (Liquaemin)FDA LinkGeneric 12/2021 - 07/2010
2	AntigensIBA 03/2021 - 05/2019
2	Carbapenems (Carbapenem Antibiotics)IBA 02/2021 - 03/2019
2	Lopinavir FDA Link 01/2021 - 01/2020
2	Vinorelbine (Navelbine)FDA LinkGeneric 01/2021 - 06/2011
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 01/2019
2	Ritonavir (Norvir)FDA Link 01/2021 - 01/2020
2	sintilimabIBA 01/2021 - 01/2021
2	Voriconazole (Vfend)FDA LinkGeneric 01/2021 - 01/2021
2	ceritinibIBA 12/2020 - 04/2017
2	Adenosine Monophosphate (AMP)IBA 12/2020 - 03/2014
2	Moxifloxacin (Avelox)FDA Link 10/2020 - 01/2015
2	Antiviral Agents (Antivirals)IBA 05/2020 - 01/2020
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020 - 01/2015
2	dioscinIBA 01/2020 - 01/2020
2	HMPL-013IBA 01/2020 - 01/2018
2	SteroidsIBA 01/2020 - 02/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 03/2009
2	Immunoglobulin M (IgM)IBA 11/2018 - 12/2017
2	Phosphotransferases (Kinase)IBA 01/2018 - 01/2015
2	anlotinibIBA 01/2018 - 01/2018

Therapy/Procedure

32	Therapeutics 10/2022 - 07/2011
29	Drug Therapy (Chemotherapy) 03/2022 - 06/2011
8	Immunotherapy 04/2021 - 03/2009
2	Artificial Respiration (Mechanical Ventilation) 06/2020 - 01/2020